ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 624

Extremely High Coronary Artery Calcium Scores Among Patients With Systemic Lupus Erythematosus

Susan Due Kay1, Anne Voss2, Axel Cosmus Pyndt Diederichsen3 and Mikael Kjær Poulsen4, 1Department of Rheumatology, Odense University hospital, University of Southern Denmark, Odense - 5000, Denmark, 2Dept of Rheumatology, Odense University Hospital, Odense C, Denmark, 3Departmen of Cardiology,, Odense University Hospital, Odens-5000, Denmark, 4Department of Cardiology, Odense University Hospital, Odense - 5000, Denmark

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, coronary artery disease and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects I - Renal, Malignancy, Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Investigations of major lupus-cohorts have demonstrated cardiovascular disease to have major impact on morbidity and mortality (Am J Epidemiol 1997;145:408-15). The aim of this study was to determine the prevalence of coronary artery calcium and pattern of coronary artery calcium scores (CAC) among Danish patients with systemic lupus erythematosus (SLE).

Methods: In a population-based predominantly Caucasian cohort we recruited 84 SLE patients. To assess CAC a Toshiba 64-slice CT-scanner (Aquilion, Toshiba Medical Systems) with the following technical settings was used: gantry rotation time 450 msec, 3 mm collimation, 120 kV tube voltage and prospective gating at 75% of the R-R interval. Scan data were acquired during an inspiratory breathhold. CAC was expressed as Agatston score, that was calculated by summing-up the scores from each foci in the coronary arteries.

Results: Among the patients 91% were females, 98 % Caucasian, 2% Arabian, and mean age was 50,8 ± 14,2 yrs.  In 43% coronary calcium was detected (CAC range 1 to 9725). Sixteen percent had a high CAC (>400), and 9% had an extremely high CAC (>1000). As shown in Table 1 patients with extremely high CAC had elevated BMI and were current smokers or previous smokers. Nephropathy and high SLICC scores were found in this group.

Table 1.

 

Coronary calciumscore >1000

Coronary calcium score 0-1000

No.

8

76

Age, yrs, mean, SD

64,8 ± 13,3

53,25 ± 10,6

Female, no. (%)

5 (62)

73 (96)

Male, no. (%)

3 (37)

4 (5)

BMI, kg/m2, mean, SD

29,5 ± 5,3

25,44 ± 5,1

Ever smoker, no. (%)

7 (87)

47 (61)

Hypertension, no. (%)

7 (87)

41 (53)

Hypercholesterolemia

5 (62)

41 (53)

Hyperglycemia, no. (%)

2 (25)

8 (10)

Nephropathy, no. (%)

3 (37)

3 (3)

Disease duration, yrs, mean, SD

4 ± 1,4

12,8 ± 7,4

SLICC, mean, SD

5,6 ± 3,8

1,7 ± 1,6

Conclusion: In a population-based cohort 9% had extremely high CAC. Traditional as well as SLE related CVD risk factor predominated among these patients.


Disclosure:

S. D. Kay,
None;

A. Voss,
None;

A. C. P. Diederichsen,
None;

M. K. Poulsen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/extremely-high-coronary-artery-calcium-scores-among-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology